Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Circulation|July 27, 1999
Interactions between electronic article surveillance systems and implantable cardioverter-defibrillatorsW J Groh, S A Boschee, E D Engelstein, et al.
The American Journal of Cardiology|December 20, 1988
Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndromeW M Miles, D P Zipes, R L Rinkenberger, et al.
The American Journal of Cardiology|December 20, 1988
Encainide for atrial fibrillation associated with Wolff-Parkinson-White syndromeR L Rinkenberger, G V Naccarelli, W M Miles, et al.
American Heart Journal|January 1, 1993
Five-year follow-up of 589 patients treated with amiodaroneB A Weinberg, W M Miles, L S Klein, et al.
Journal of the American College of Cardiology|November 15, 1989
Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidineM S Stanton, M M Tuli, N L Radtke, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 15, 2002
Induction of labour with a viable infant: a randomised clinical trial comparing intravaginal misoprostol and intravaginal dinoprostoneP Rozenberg, S Chevret, F Goffinet, et al.
Journal of the American College of Cardiology|June 1, 1985
Criteria for intraventricular conduction disturbances and pre-excitation. World Health Organizational/International Society and Federation for Cardiology Task Force Ad HocJ L Willems, E O Robles de Medina, R Bernard, et al.
Fertility and Sterility|December 4, 2018
Precocious subcutaneous abdominal stem cell development to adipocytes in normal-weight women with polycystic ovary syndromeSamantha C Fisch, Ariella Farzan Nikou, Elizabeth A Wright, et al.
Schizophrenia Research|August 20, 2013
Toxoplasma gondii exposure affects neural processing speed as measured by acoustic startle latency in schizophrenia and controlsBradley D Pearce, Sydney Hubbard, Hilda N Rivera, et al.
Leukemia Research|June 6, 2025
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503)Brian A Jonas, Samantha C Fisch, Peter T Curtin, et al.
Pageof 12